These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9745778)

  • 21. Measles and rubella antibody response after measles-mumps-rubella vaccination in children with afebrile upper respiratory tract infection.
    Ratnam S; West R; Gadag V
    J Pediatr; 1995 Sep; 127(3):432-4. PubMed ID: 7658276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
    Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M
    Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles, mumps, and rubella antibodies in vaccinated Baltimore children.
    King JC; Lichenstein R; Feigelman S; Luna C; Permutt TJ; Patel J
    Am J Dis Child; 1993 May; 147(5):558-60. PubMed ID: 8488803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and immunogenicity of concurrent administration of measles-mumps-rubella-varicella vaccine and PedvaxHIB vaccines in healthy children twelve to eighteen months old. The MMRV Study Group.
    Reuman PD; Sawyer MH; Kuter BJ; Matthews H
    Pediatr Infect Dis J; 1997 Jul; 16(7):662-7. PubMed ID: 9239770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
    Matter L; Germann D; Bally F; Schopfer K
    Eur J Epidemiol; 1997 Jan; 13(1):61-6. PubMed ID: 9062781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug clinics. Drug of the month. A new measles-rubella-mumps vaccine (Priorix)].
    Senterre J
    Rev Med Liege; 1999 Feb; 54(2):122-4. PubMed ID: 10221066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
    King SM; Saunders EF; Petric M; Gold R
    Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative evaluation of two combined measles-mumps-rubella vaccines based on AIK and Edmonston- Zagreb strains of measles virus.
    Mirchamsy H; Nilforoushan MA; Shafyi A; Razavi J; Ashtiani MP; Youssofi I; Sassani A; Fateh G; Nassiri S
    Kitasato Arch Exp Med; 1991 Sep; 64(2-3):141-7. PubMed ID: 1811112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
    Goujon C; Gougeon ML; Tondeur L; Poirier B; Seffer V; Desprès P; Consigny PH; Vray M;
    Vaccine; 2017 Oct; 35(45):6166-6171. PubMed ID: 28958813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; McLean AA; Hilleman MR
    Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A search for persistent measles, mumps, and rubella vaccine virus in children with human immunodeficiency virus type 1 infection.
    Frenkel LM; Nielsen K; Garakian A; Cherry JD
    Arch Pediatr Adolesc Med; 1994 Jan; 148(1):57-60. PubMed ID: 8143011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A; Gerike E
    Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland.
    Davidkin I; Peltola H; Leinikki P; Valle M
    Vaccine; 2000 Jul; 18(27):3106-12. PubMed ID: 10856790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to measles revaccination among toddlers in Saudi Arabia by the use of two different trivalent measles-mumps-rubella vaccines.
    Khalil M; Poltera AA; al-Howasi M; Herzog C; Gerike E; Wegmüller B; Glück R
    Trans R Soc Trop Med Hyg; 1999; 93(2):214-9. PubMed ID: 10450452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination. Should we be concerned?
    Watada B; Kennedy K; Chan D; Church B; Patriquin M; Shariff F; Evans MF
    Can Fam Physician; 1998 Jan; 44():53-5. PubMed ID: 9481462
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccines.
    Wegmann A; Glück R; Just M; Mischler R; Paroz P; Germanier R
    Dev Biol Stand; 1986; 65():69-74. PubMed ID: 3556778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation.
    Pauksen K; Duraj V; Ljungman P; Sjölin J; Oberg G; Lönnerholm G; Fridell E; Smedmyr B; Simonsson B
    Bone Marrow Transplant; 1992 Jun; 9(6):427-32. PubMed ID: 1628126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indications for measles-mumps-rubella vaccination in a child with prior thrombocytopenia purpura.
    Pool V; Chen R; Rhodes P
    Pediatr Infect Dis J; 1997 Apr; 16(4):423-4. PubMed ID: 9109153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.